Dr. Pierre Kory: COVID Early Treatments Work

Dr. Pierre Kory is a Pulmonary and Critical Care specialist and the President of the Front-Line COVID-19 Critical Care Alliance (FLCCC).

Dr. Kory told The New American about the fantastic results that FLCCC Alliance was able to achieve by treating COVID patients with repurposed drugs such as Ivermectin. He also told The New American how the U.S. health authorities, which he calls “federal pharmaceutical agencies," suppress early treatments to protect Big Pharma’s bottom lines. He also said that the Omicron strain of COVID that is currently dominating the United States may be potentially very good news, since it would help many people to develop natural immunity that is far more superior than immunity generated by the vaccines.

To learn more, go to https://covid19criticalcare.com/

Dr. Kory can be found at https://pierrekory.substack.com/?utm_source=discover_search